Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian A Rowe

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Journal of Hepatology|August 18, 2016
High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver diseaseDitte L Hedegaard, Damien C Tully, Ian A Rowe, et al.
Nature Reviews. Gastroenterology & Hepatology|July 17, 2024
A roadmap for clinical trials in MASH-related compensated cirrhosisJuan M Pericàs, Quentin M Anstee, Salvador Augustin, et al.
Nature Reviews. Gastroenterology & Hepatology|August 5, 2024
Author Correction: A roadmap for clinical trials in MASH-related compensated cirrhosisJuan M Pericàs, Quentin M Anstee, Salvador Augustin, et al.
The Lancet Regional Health. Europe|November 12, 2024
Liver transplantation for critically ill patients with acute on chronic liver failure: a prospective national programme of waitlist prioritisationWilliam Bernal, Rhiannon Taylor, Ian A Rowe, et al.
Journal of Hepatology|December 20, 2011
A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migrationGarrick K Wilson, Claire L Brimacombe, Ian A Rowe, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 6, 2015
Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantationIan A Rowe, Damien C Tully, Matthew J Armstrong, et al.
Gastroenterology|December 6, 2011
Hepatitis C virus infects the endothelial cells of the blood-brain barrierNicola F Fletcher, Garrick K Wilson, Jacinta Murray, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 31, 2021
Trajectory of Serum Bilirubin Predicts Spontaneous Recovery in a Real-World Cohort of Patients With Alcoholic HepatitisRichard Parker, Joaquin Cabezas, Jose Altamirano, et al.
Hepatology (Baltimore, Md.)|January 24, 2021
Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus StatementHannes Hagström, Leon A Adams, Alina M Allen, et al.
The Lancet. Gastroenterology & Hepatology|May 1, 2022
Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest GroupStuart McPherson, Matthew J Armstrong, Jeremy F Cobbold, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Journal of Hepatology|August 18, 2016
High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver diseaseDitte L Hedegaard, Damien C Tully, Ian A Rowe, et al.
Nature Reviews. Gastroenterology & Hepatology|July 17, 2024
A roadmap for clinical trials in MASH-related compensated cirrhosisJuan M Pericàs, Quentin M Anstee, Salvador Augustin, et al.
Nature Reviews. Gastroenterology & Hepatology|August 5, 2024
Author Correction: A roadmap for clinical trials in MASH-related compensated cirrhosisJuan M Pericàs, Quentin M Anstee, Salvador Augustin, et al.
The Lancet Regional Health. Europe|November 12, 2024
Liver transplantation for critically ill patients with acute on chronic liver failure: a prospective national programme of waitlist prioritisationWilliam Bernal, Rhiannon Taylor, Ian A Rowe, et al.
Journal of Hepatology|December 20, 2011
A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migrationGarrick K Wilson, Claire L Brimacombe, Ian A Rowe, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 6, 2015
Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantationIan A Rowe, Damien C Tully, Matthew J Armstrong, et al.
Gastroenterology|December 6, 2011
Hepatitis C virus infects the endothelial cells of the blood-brain barrierNicola F Fletcher, Garrick K Wilson, Jacinta Murray, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 31, 2021
Trajectory of Serum Bilirubin Predicts Spontaneous Recovery in a Real-World Cohort of Patients With Alcoholic HepatitisRichard Parker, Joaquin Cabezas, Jose Altamirano, et al.
Hepatology (Baltimore, Md.)|January 24, 2021
Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus StatementHannes Hagström, Leon A Adams, Alina M Allen, et al.
The Lancet. Gastroenterology & Hepatology|May 1, 2022
Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest GroupStuart McPherson, Matthew J Armstrong, Jeremy F Cobbold, et al.
Pageof 10